Recon Technology, Ltd. (NASDAQ:RCON) Signs $2 Million China Deal

Recon Technology, Ltd. (NASDAQ:RCON)

Recon Technology, Ltd. (NASDAQ:RCON) shares gained 7% after the Chinese software maker announced the signing of a $2 million deal with Qinghai Oilfield Company, a PetroChina subsidiary. The agreement is for the supply of the company’s proprietary chemical compound agents and microbiological treatment agents for oil sewage treatment.

Recon Technology, Ltd. (NASDAQ:RCON)

RCON Investors Reaction

Investors initially pushed the stock up 30% to $2.60, before it dropped to end the day at $1.82 a share. The rally affirmed a bullish run on the stock that began earlier in the month. The stock is up by more than 40% for the year as it continues to trade in a strong uptrend. The stock faces immediate resistance at the $2.64 level – its 52-week high.

The Qinghai Oil Field agreement represents a significant size increase in Recon Technology, Ltd. (NASDAQ:RCON) wastewater treatment agreement. The company will begin recording revenues under the project in the current quarter. All goods to be delivered for the project will be delivered by the company.

“This is a major progression in our partnership with Qinghai Oilfield, and an indication of the upside potential of Recon in the oilfield environmental protection market. Our oilfield waste water treatment business has continued to expand rapidly, as agreements have continued to grow in terms of size and number. In fiscal 2017, we grew our revenue in this business by over 371%,” said CEO Yin Shenping.

According to Mr. Shenping, wastewater treatment represents a significant opportunity that should accelerate the company’s next phase of growth. As countries push for greater environmental protection, Increased regulatory oversight should be a key driver of demand for Recon Technology, Ltd. (NASDAQ:RCON) products.

 

Sewage Treatment Strategic Cooperation Agreement

In addition, Recon Technology, Ltd. (NASDAQ:RCON) has signed a three-year strategic cooperation agreement with Beijing OriginWater Purification Engineering Technology Co. Pursuant to the agreement, the two companies are to join forces for the promotion of advanced sewage treatment technology in Chinese oilfield markets. The two companies are also to work together in providing interactive solutions and services for tackling industrial water pollution.

“Recon Technology has provided reliable and efficient technologies to China’s major oilfield companies, such as CNPC and Sinopec, for years. Recon Technology has made some strides in oily sewage treatment for last two years,” said Mr. Shenping.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $RCON and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Long Island Iced Tea Corp (NASDAQ:LTEA)

Investors Lapping up Long Island Iced Tea Corp (NASDAQ:LTEA)

Long Island Iced Tea Corp (NASDAQ:LTEA)

Shares of Long Island Iced Tea Corp (NASDAQ:LTEA) are up over 15% after the beverage company released preliminary unaudited net sales results for the three and nine-month periods ended September 30, 2017. Volume has been heavy. Shares are trading over ten times their 30-day, daily average.

Long Island Iced Tea Corp (NASDAQ:LTEA)

Philip Thomas, Chief Executive Officer of the Company, commented, “Through the first half of 2017, we undertook a number of foundational projects to set the framework for future growth, the most notable of these being the March 2017 relaunch of our flagship Long Island Iced Tea® brand into a new 18oz slimline bottle and the April 2017 appointment of Big Geyser as our exclusive Long Island Iced Tea® distributor in the New York region. Following the successful execution of these projects, we expect to report another milestone quarter, achieving approximately 67% branded business net sales growth over the previous corresponding period, and continuing our solid growth trajectory.”

Preliminary Results

Estimated net sales for Long Island Iced Tea Corp (NASDAQ:LTEA) branded business is expected to increase approximately 67% to approximately $1,371,994 for the three months ended September 30, 2017, as compared to $822,389 for the comparable prior-year period. Estimated total net sales is expected to increase approximately 26% to approximately $1,644,000 for the three months ended September 30, 2017, as compared to $1,301,125 for the comparable prior-year period.

LTEA Stock Performance

Long Island Iced Tea Corp (NASDAQ:LTEA) stock peaked in June when shares touched $6.68 tpo establish a new 52-week high. However, since then, LTEA stock has been on a slide a was trading in a tight range around the $2.50 handle for most of October. Prior to today’s action, the beverage company’s stock had lost almost 60% over the past year and over 44% over the past six months.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $LTEA and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

SenesTech Inc (NASDAQ:SNES) Gets Boost from Distribution Agreement

SenesTech Inc (NASDAQ:SNES)

SenesTech Inc (NASDAQ:SNES) stock is up over 75% in the first 1.5 hours of trading after the company announced a national distribution agreement with Univar. The thinly traded pest-control company typically trades less than 100,000 shares per day but one hour into today’s session over 420,000 shares have exchanged hands.

Shares of SenesTech Inc (NASDAQ:SNES)

Dr. Loretta P. Mayer, Chair, CEO and co-founder of SenesTech stated in a press release “Univar is an excellent sales and distribution partner for SenesTech, with their extensive breadth and depth of coverage, their direct connection with the pest control operators, and their commitment to sustainability. They will immediately provide us with nationwide sales coverage and nine dedicated sales representatives. As they have assured us, as our distributor, Univar sees their role as an active partner in creating and building a market for ContraPest.”

ContraPest is a liquid fertility control bait for rodents that targets the reproductive capacity of both male and female rats, rendering them infertile.

SNES Stock Review

Shares of SenesTech Inc (NASDAQ:SNES) recently touched $1.58 which established a new 52-week low. The 52-week high, $10.69, was established in early 2017. SNES shares are down over 80% year-to-date despite having sales that have increased from $200,000 in 2014 to $300,000 in 2016. Per share losses shrunk from (-$1.80) in 2015 to (-$1.08) for 2016. Additionally, the company has managed to keep the number of outstanding shares at the same level (10.13 million) for the last three years, thereby avoiding shareholder dilution that sometimes accompanies companies in rapid growth.

Analysts have given SNES shares a 1-year consensus price target of $14 according to the NASDAQ.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $SNES and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Monica has an undergraduate degree in Accounting and an MBA she earned – with Honors. She has six years of experience in the financial markets and has been an analyst for the past two years.

EnerJex Resources Inc. (NYSEAMERICAN:ENRJ) Expanding Into Agriculture

EnerJex Resources Inc. (NYSEAMERICAN:ENRJ)

EnerJex Resources Inc. (NYSEAMERICAN:ENRJ) shares gained 43.9% after the independent energy company announced it had entered into a merger definitive agreement with AgEagle Aerial Systems. The merger will expand the company’s footprint into the commercial agriculture drone business.

AgEagle boasts a product portfolio designed to help improve farming techniques with GPS technology and high-resolution aerial imagery. The precision agriculture sector presents unique growth opportunities given that there are more than 2.1 million farms that the combined company will be able to target.

“Our goal at EnerJex has been to maximize stockholder value and we believe AgEagle, with its strong leadership team, is well-positioned to capitalize on the fast-growing agriculture drone market,” said Louis Schott, CEO of EnerJex. “While AgEagle is focused on the agriculture market, we believe there is opportunity for drones in the oil and gas.

Investor’s reaction to the proposed merger has been positive seen by the stock breaking a key resistance level after consolodating for the better part of the year. The stock is now up by more than 30% for the year.

Merger Agreement

Under the terms of the merger agreement, EnerJex Resources Inc. (NYSEAMERICAN:ENRJ)’s Series A preferred shareholders are to own approximately 15% of the combined company. The transaction values AgEagle at $20 million prior to any financing. Each company’s board of directors have approved the proposed merger, which is set to be finalized in the fourth quarter.

However, shareholders of both EnerJex Resources Inc. (NYSEAMERICAN:ENRJ) and AgEagle must approve the transaction before it is consummated. Other closing conditions include the raising of at least $4 million, and approval by the NYSE for the listing of the combined company’s common stock.

EnerJex has announced plans to divest its principal assets including its Kansas oil and gas properties in anticipation of the merger.

Non-Compliance Notice

Separately, EnerJex Resources Inc. (NYSEAMERICAN:ENRJ) has received a notice of non-compliance from the NASDAQ Capital Market. The notice raises concerns about the stockholder’s equity which has fallen below the minimum $2 million requirements. The share price is another concern – it has dropped below the $1 a share bid requirement

EnerJex Resources Inc. (NYSEAMERICAN:ENRJ) has since been given until November 19, 2017, to file a detailed plan on how it plans to regain compliance before April 19, 2019.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $ENRJ and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Riot Blockchain Inc. (NASDAQ:BIOP)

Riot Blockchain Inc. (NASDAQ:BIOP)

Riot Blockchain Inc. (NASDAQ:BIOP)

Riot Blockchain Inc. (NASDAQ:BIOP) traded higher after announcing it had entered into a definitive agreement for the acquisition of a 52% stake in Toronto-based Tess Inc. The stock was up by 7.7% in Tuesday’s trading session to end the day at $8.13 a share.

Riot Blockchain Inc. (NASDAQ:BIOP)

BIOP Stock Performance

The acquisition reflects a change of focus which has seen Riot Blockchain tweak its operations to focus on the blockchain ecosystem. Given the hype around Bitcoin, the change has helped strengthen investor confidence on the stock. The company joins the likes of MGT Capital Investments Inc. (OTCMKTS:MGTI) and Overstock.com, Inc. (NASDAQ:OSTK) that have seen their share price explode.

Over the past one month, Riot Blockchain Inc. (NASDAQ:BIOP) has gained more than 60% in market value. The stock is also up by more than 100% for the year. Renewed investor interest in the stock does not come as a surprise given that bitcoin has also touched all-time highs in the market over the same period.

Tess’ acquisition will expand Riot Blockchain operations into the payment services business built around blockchain technology. The company is currently developing a guaranteed payment system using blockchain-based escrow service for telecom carriers.

“Our affiliation with Riot Blockchain will give us better access to the capital markets in the United States, as well as the availability of additional senior management resources, all in aid of our ambitious business plans around blockchain,” said TESS CEO, Jeff Mason.

Coinsquare Investment

The acquisition of a controlling stake in TESS builds on a strategic investment on Coinsquare, one of Canada’s leading exchanges for digital currencies. Riot Blockchain has reportedly paid a few million dollars for a 12% stake in the company. The investment underscores how committed the company is, in pursuing growth opportunities around blockchain technologies.

Riot Blockchain has already started to divest a number of intellectual Properties tied to the diagnostics industry, as it looks for additional capital to pursue opportunities in the digital currencies business.

Separately, Riot Blockchain Inc. (NASDAQ:BIOP) formerly Bioptix Inc. announced a special dividend of $1 per common share. According to the Chief Executive Officer Michael Beeghley, the dividend underscores the company’s commitment to returning value to shareholders.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $BIOP and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

Capstone Turbine Corporation (NASDAQ:CPST)

Capstone Turbine Corporation (NASDAQ:CPST) Cost Cutting Drive

Capstone Turbine Corporation (NASDAQ:CPST)

Capstone Turbine Corporation (NASDAQ:CPST) shares fell 7.76% after the leading manufacturer of microturbine energy systems announced a reduction in its quarterly operating-expense target. The company has lowered, following the restructuring of engineering assets and other cost reduction activities, its target from $5.5 million per quarter to $5 million.

CPST Stock Performance

Shares of Capstone Turbine had initially recorded a new 52-week high of $1.38 a share after Oppenheimer analysts upgraded the stock to an ‘outperform’. However, the stock came under pressure in Friday’s trading session as it dropped to end the week at $1.70 a share.

Capstone Turbine Corporation (NASDAQ:CPST) is currently trading in an uptrend despite Friday’s sell-off. A price target of $2 by Oppenheimer analysts appears to have strengthened sentiments on the stock. The analysts see potential upside in the stock price, given that the company is set to move its manufacturing operations to a more affordable space as it also continues to aggressively manage its supply chain.

 

Capstone Turbine Corporation (NASDAQ:CPST) has also announced that it is completing the previously announced $5.2 million retrofit program. The program seeks to upgrade non-signature series C100 and C200 microturbine to provide improved performance and reliability.

Capstone Forecast

According to Capstone Turbine Corporation (NASDAQ:CPST), improved reliability of the microturbine coupled with high performing Signature series microturbine could drive higher gross margins in the accessories, parts, and service divisions.

“We need to drive Capstone to profitability as quickly as possible in order to fuel Capstone’s launch to the next level of product development and market penetration. Our aftermarket service business growth is a critical element of our multi-point strategic plan to quickly achieve Adjusted EBITDA breakeven,” said CEO Darren Jamison.

Capstone Turbine Corporation (NASDAQ:CPST) is targeting revenues of up to $10 million, on gross margins of 50%, for its accessories, parts, and service business. The company has moved from a high-cost, three department research and development effort to a single consolidated department in pursuit of lower costs and improved efficiency on product optimization. Operating expenses as a result dropped 42% from $10.5 million as of Q1 2016 to $6.1 million in Q3 2017.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $CPST Symbol and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Traders Cautious on Jump in Leading Brands, Inc (USA) (NASDAQ:LBIX) Stock

Leading Brands, Inc (USA) (NASDAQ:LBIX)

Nano-cap Leading Brands, Inc (USA) (NASDAQ:LBIX) stocked rocketed over 68% Friday to end the day at $2.27 on volume over 128 times its 30-day, daily average.

Leading Brands, Inc (USA) (NASDAQ:LBIX)

About Leading Brands Inc.

Nano-cap Leading Brands, Inc (USA) (NASDAQ:LBIX) is headquartered in Vancouver, BC, Canada. It develops, markets, and distributes beverages in Canada, the western United States, and Asia. The company’s core product lines include premium spring waters and fruit juices. The company was formerly known as Brio Industries Inc. and changed its name to Leading Brands, Inc. in October 1999.

Some nano-cap observers believe the dramatic increase of Leading Brands, Inc (USA) (NASDAQ:LBIX) stock last week could be due to speculation that traders may be betting on a play in the near future by a braoder market than usual based on the recent moves by former nano-cap Helios and Matheson Analytics Inc (NASDAQ:HMNY). HMNY shares are up over 675% in the past month.

However, it should be noted that while LBIX shares have increased 134% over the past month, the beverage company has not released any news that would point to a dramatic increase in revenues or earnings as Helios and Matheson Analytics did.

LBIX Stock

In 2015, Leading Brands, Inc (USA) (NASDAQ:LBIX) posted sales of $400,000 and that sales figure improved to $1 million for 2016. Also to the benefit of LBIX shareholders is the fact that, according to reports, the number of outstanding shares has declined each year since 2013. However LBIX shares have posted per share losses each of the last three years, In 2015 investors lost (-$1.05) per share, (-$1.09) in 2015, and (-$0.88) for 2016.

Until last week, shares of Leading Brands, Inc (USA) (NASDAQ:LBIX) had been sliding since May when they last hit $2.27. The price action on Friday saw LBIX shares hit an inter-day high of $3.75 which is considerably over their 52-week high of $2.92.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $LBIX and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Reuters Article Propels Helios and Matheson Analytics Inc (NASDAQ:HMNY)

Helios and Matheson Analytics Inc (NASDAQ:HMNY)

Helios and Matheson Analytics Inc (NASDAQ:HMNY) stock has been covered by StockNewsUnion.com nine times since December of 2016 and the company is now being covered by financial news giant Reuters. In an article published today. Reuters raised the possibility that Helios and Matheson Analytics Inc (NASDAQ:HMNY) could be a billion dollar company – tapping into a business model similar to Netflix. The news article has sent the stock screaming higher.

Helios and Matheson Analytics Inc (NASDAQ:HMNY)

Helios and Matheson Business Model

Today the stock opened strong and HMNY stock is up over 20% this morning on heavy volumes. Over the past month HMNY shares have increased over 10-fold. According to the Reuters article “The ticketing service, led by Netflix co-founder Mitch Lowe, is seeking to spur the sort of revolution for the movie business that Ryanair did for airlines or Netflix did for streaming. The alliance between the two firms dates exactly to the moment earlier this year when MoviePass slashed all its variable subscription fees in favor of a single $9.95 model, allowing unlimited access to more than 90 percent of U.S. theaters. In the month that followed, the company’s subscriber numbers rose to over 400,000 from less than 20,000.”

On September 18, 2017 StockNewsUnion reported that Helios and Matheson Analytics Inc. (NASDAQ:HMNY) was a big mover after its latest acquisition, MoviePass Inc., announced it had surpassed 400,000 paying monthly subscribers over the last 30 days. The stock rallied 39.54% to end that week’s trading session at a high of $3.67 a share. At the time of the article, Mitch Lowe, co-founder of Netflix Inc. (NFLX), former president of RedBox, and current CEO of MoviePass said in a press release, “MoviePass is the ‘all-you-can-eat’ movie theater experience. Though expensive for the company in the short-term, it’s a significant benefit and more convenient for customers. With MoviePass, there’s no movie ticket prices to think about — going to the movies will become an everyday experience rather than an occasional treat.”

HMNY Stock Performance

Clearly investors are in love with Helios and Matheson Analytics Inc (NASDAQ:HMNY). Well above their 52-week low of $2.20, HMNY shares have a Relative Strength Index (RSI) figure exceeding 97. This is a figure that unquestionably signifies “rare air” in trading circles. Traders would agree that an RSI level of 80 is a clear “overbought” signal.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $HMNY and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

Riot Blockchain Inc. (NASDAQ:BIOP)

Riot Blockchain Inc. (NASDAQ:BIOP) Quits Diagnostic Equipment Business

Riot Blockchain Inc. (NASDAQ:BIOP)

Shares of Riot Blockchain Inc. (NASDAQ:BIOP) gained 18.1% after the maker of diagnostic machinery announced it was rebranding itself to focus on cryptocurrency and blockchain businesses. The company has since announced a strategic investment in Coinsquare Ltd, a leading digital currency exchange company.

Riot Blockchain Inc. (NASDAQ:BIOP)

Riot Blockchain Bitcoin Push

The rebranding push has resulted in the stock more than doubling in value since the start of the month. BIOP is up by more than 100% for the year as investors apparently remain confident about its prospects in the cryptocurrency business.

However, it is not the first company to be rewarded heavily by investors after expanding into the cryptocurrency space. Overstock.com and MGT Capital Investments also experienced astronomical increases in value after expanding their operations into the bitcoin space.

Riot Blockchain Inc. (NASDAQ:BIOP) has enjoyed a fair share amount of drama. Last year Venaxis acquired Bioptix Diagnostics and then renamed it Bioptix Inc. The acquisition quickly turned nasty after major shareholders accused the company’s executives of an “inside” job to benefit themselves.

In January, the company also found itself in trouble after three board members tendered their resignation. The company afterward announced job cuts as it sought to stay afloat by pursuing strategic alternatives.

Fast forward, Riot Blockchain is hoping to reinvent itself by investing in blockchain technologies and companies.

“With new applications being developed for blockchain every day, this is a rapidly growing and evolving market. We are excited to have partnered with and led an investment in Coinsquare, a company we believe is well positioned to capitalize on the opportunity in this sector,” said CEO Michael Beeghley.

Riot Blockchain Acquisition Play

Riot Blockchain Inc. (NASDAQ:BIOP) has paid a few million dollars for a 12% stake in Coinsquare. The company has also acquired warrants which it can use to increase its stake to 20%.

The Chief Executive Officer has also announced plans to buy companies focused on bitcoin mining, blockchain, and associated software. The deals are to be financed by a combination of cash and stock. In order to raise cash, the company is selling patents and intellectual property to a private company. The company expects as much as $2.5 million from the transactions.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $BIOP and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Tenax Therapeutics Inc. (NASDAQ:TENX)

Is Tenax Therapeutics Inc. (NASDAQ:TENX) Sell-Off Over?

Tenax Therapeutics Inc. (NASDAQ:TENX)

Shares of Tenax Therapeutics Inc. (NASDAQ:TENX) gained 34.16% in Friday’s trading session, to end the week at $0.5098 a share.  The specialty pharmaceutical company has come under pressure this year as investors continue to question its long-term growth prospects.

TENX Stock Performance

TENX is down by more than 70% for the year as the pharmaceutical company failed to issue updates detailing developments on ongoing clinical programs.

Tenax Therapeutics Inc. (NASDAQ:TENX)

In July, Tenax Therapeutics Inc. (NASDAQ:TENX) held discussions with the U.S. Food and Drug Administration (FDA) regarding the regulatory pathway for Levosimendan. The company is investigating the candidate drug as a treatment option for patients undergoing coronary artery bypass grafting (CABG), to reduce the risk of low cardiac output syndrome. Levosimendan is also in trials for the treatment of patients with acute decompensated heart failure.

Positive Levosimendan Clinical Trials

The FDA meeting concentrated on additional analysis of Levosimendan surrounding 66% of the patients in the LEVO-CTS trial who underwent CABG alone. Initial clinical trial results indicate that patients who participated in the trial benefited from a highly significant 73% relative risk reduction in all-cause mortality.

“We are encouraged to find the data generated from the LEVO-CTS supports our continued belief that Levosimendan is an effective and safe inotrope to increase cardiac output in CABG only patients at risk for developing perioperative low cardiac output syndrome,” said CEO Michael Jebsen.

Tenax Therapeutics Inc. (NASDAQ:TENX) is currently awaiting a decision from the FDA on whether Levosimendan’s New Drug Application for the treatment of coronary bypass surgery can be filed. The agency has requested for additional information from published cross-study analyses to aid in its final decision.

Tenax Therapeutics is reviewing a number of strategic alternatives with the assistance of Ladenburg Thalmann & Co. Some of the strategies under review include a merger or a strategic investment into the company. The company is also reportedly open to license agreements as well as the acquisition of assets.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $TENX and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Monica has an undergraduate degree in Accounting and an MBA she earned – with Honors. She has six years of experience in the financial markets and has been an analyst for the past two years.